Table 2.
Odds Ratio for Confirmed Cases of MERS-CoV Infection.
Variable | OR (95% CI) | P-value | AOR (95% CI) | P-value |
---|---|---|---|---|
Age | – | – | 1.06 (1.02–1.098) | 0.004 |
Gender | ||||
Male | 2.47 (1.71–3.56) | <0.001 | 1.617 (1.365–1.77) | <0.001 |
Comorbidities | ||||
Diabetes | 3.28 (1.841–5.867) | <0.001 | 1.68 (1.346–1.848) | 0.002 |
Hypertension | 1.64 (0.88–2.34) | 0.2 | 1.2 (0.87–1.64) | 0.2 |
Chronic Kidney Disease | 2.43 (1.22–4.67) | 0.004 | 1.6 (0.64–3.22) | 0.5 |
Asthma/COPD | 1.87 (0.98–3.66) | 0.09 | 1.47 (0.82–3.56) | 0.2 |
Medications | ||||
Metformin | 0.814 (0.811–1.65) | 0.07 | 1.131 (0.95–1.37) | 0.012 |
Sulfonylureas | 1.25 (0.815–1.35) | 0.1 | 1.126 (0.803–1.58) | 0.89 |
DDP4 inhibitors | – | – | – | – |
ACEI/ARB | 0.64 (0.43–3.95) | 0.028 | 1.19 (0.675–1.52) | 0.224 |
Diuretics | 0.968 (0.79–1.4) | 0.93 | 1.987 (0.76–4.87) | 0.27 |
BB | 0.945 (0.655–1.34) | 0.3 | 1.112 (0.62–2.244) | 0.02 |
OR: odds ratio; 95% CI: 95% confidence interval.
ACEI/ARB = angiotensin converting enzyme inhibitor and/or receptor blocker, BB = beta blocker.